Valneva shares are trading higher after the company announced that the European Medicines Agency has validated the Marketing Authorization Application for PF-07307405.

Benzinga Newsdesk www.benzinga.com Positive 95.1%

Neg 0% Neu 0% Pos 95.1%

Comments

No comments yet. Be the first!